Loss of D2 dopamine receptor function modulates cocaine-induced glutamatergic synaptic potentiation in the ventral tegmental area

Journal of Neuroscience

Volumn 33, Issue 30, 2013, Pages 12329-12336

  Madhavan, Anuradha ^a,b   Argilli, Emanuela ^b   Bonci, Antonello ^b,c,d   Whistler, Jennifer L ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; COCAINE; DOPAMINE 2 RECEPTOR; G PROTEIN ASSOCIATED SORTING PROTEIN 1; GUANINE NUCLEOTIDE BINDING PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; DOWN REGULATION; EXCITATORY POSTSYNAPTIC POTENTIAL; GLUTAMATERGIC NERVE CELL; LONG TERM POTENTIATION; MALE; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC POTENTIAL; VENTRAL TEGMENTUM; WESTERN BLOTTING;

ANIMALS; ANTIPSYCHOTIC AGENTS; CARRIER PROTEINS; COCAINE; DOPAMINE UPTAKE INHIBITORS; DOWN-REGULATION; EXCITATORY POSTSYNAPTIC POTENTIALS; FEMALE; GLUTAMIC ACID; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONAL PLASTICITY; ORGAN CULTURE TECHNIQUES; PIPERAZINES; QUINOLONES; RECEPTORS, AMPA; RECEPTORS, DOPAMINE D2; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTIC POTENTIALS; VENTRAL TEGMENTAL AREA;

EID: 84880601622     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0809-13.2013     Document Type: Article

References (42)

1. Adell A, Artigas F (2004) The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems. Neurosci Biobehav Rev 28:415-431. CrossRef Medline
2. Allen JA, Yost JM, Setola V, Chen X, Sassano MF, Chen M, Peterson S, Yadav PN, Huang XP, Feng B, Jensen NH, Che X, Bai X, Frye SV, Wetsel WC, Caron MG, Javitch JA, Roth BL, Jin J (2011) Discovery of beta-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy. Proc Natl Acad Sci U S A 108:18488-18493. CrossRef Medline
3. Argilli E, Sibley DR, Malenka RC, England PM, Bonci A (2008) Mechanism and time course of cocaine-induced long-term potentiation in the ventral tegmental area. J Neurosci 28:9092-9100. CrossRef Medline
4. Attarbaschi T, Sacher J, Geiss-Granadia T, Klein N, Mossaheb N, Lanzenberger R, Asenbaum S, Dudczak R, Kasper S, Tauscher J (2007) Striatal D(2) receptor occupancy in bipolar patients treated with olanzapine. Eur Neuropsychopharmacol 17:102-107. CrossRef Medline
5. Bartlett SE, Enquist J, Hopf FW, Lee JH, Gladher F, Kharazia V, Waldhoer M, Mailliard WS, Armstrong R, Bonci A, Whistler JL (2005) Dopamine responsiveness is regulated by targeted sorting of D2 receptors. Proc Natl Acad Sci U S A 102:11521-11526. CrossRef Medline
6. Boeuf J, Trigo JM, Moreau PH, Lecourtier L, Vogel E, Cassel JC, Mathis C, Klosen P, Maldonado R, Simonin F (2009) Attenuated behavioural responses to acute and chronic cocaine in GASP-1-deficient mice. Eur J Neurosci 30:860-868. CrossRef Medline
7. Borgland SL, Malenka RC, Bonci A (2004) Acute and chronic cocaineinduced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats. J Neurosci 24:7482-7490. CrossRef Medline
8. Bowers MS, Chen BT, Bonci A (2010) AMPA receptor synaptic plasticity induced by psychostimulants: the past, present, and therapeutic future. Neuron 67:11-24. CrossRef Medline
9. Boyson SJ, McGonigle P, Molinoff PB (1986) Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain. J Neurosci 6:3177-3188. Medline
10. Burris KD, Molski TF, Xu C, Ryan E, Tottori K, Kikuchi T, Yocca FD, Molinoff PB (2002) Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther 302:381-389. CrossRef Medline
11. Chen BT, Bowers MS, Martin M, Hopf FW, Guillory AM, Carelli RM, Chou JK, Bonci A (2008) Cocaine but not natural reward self-administration nor passive cocaine infusion produces persistent LTP in the VTA. Neuron 59:288-297. CrossRef Medline
12. Chen JF, Aloyo VJ, Weiss B (1993) Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum. Neuroscience 54: 669-680. CrossRef Medline
13. Ciliax BJ, Nash N, Heilman C, Sunahara R, Hartney A, Tiberi M, Rye DB, Caron MG, Niznik HB, Levey AI (2000) Dopamine D(5) receptor immunolocalization in rat and monkey brain. Synapse 37:125-145. CrossRef Medline
14. Feltenstein MW, Altar CA, See RE (2007) Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse. Biol Psychiatry 61:582-590. CrossRef Medline
15. Giros B, el Mestikawy S, Bertrand L, Caron MG (1991) Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett 295:149-154. CrossRef Medline
16. Harris GC, Aston-Jones G (2003) Critical role for ventral tegmental glutamate in preference for a cocaine-conditioned environment. Neuropsychopharmacology 28:73-76. CrossRef Medline
17. Huang YH, Lin Y, Mu P, Lee BR, Brown TE, Wayman G, Marie H, Liu W, Yan Z, Sorg BA, Schluter OM, Zukin RS, Dong Y (2009) In vivo cocaine experience generates silent synapses. Neuron 63:40-47. CrossRef Medline
18. Iravani MM, Muscat R, Kruk ZL (1996) Comparison of somatodendritic and axon terminal dopamine release in the ventral tegmental area and the nucleus accumbens. Neuroscience 70:1025-1037. CrossRef Medline
19. Jones SR, Gainetdinov RR, Hu XT, Cooper DC, Wightman RM, White FJ, Caron MG (1999) Loss of autoreceptor functions in mice lacking the dopamine transporter. Nat Neurosci 2:649-655. CrossRef Medline
20. Kalivas PW, Alesdatter JE (1993) Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J Pharmacol Exp Ther 267:486-495. Medline
21. Khan ZU, Gutiérrez A, Martín R, Peñafiel A, Rivera A, de la Calle A (2000) Dopamine D5 receptors of rat and human brain. Neuroscience 100:689-699. CrossRef Medline
22. Kilty JE, Lorang D, Amara SG (1991) Cloning and expression of a cocainesensitive rat dopamine transporter. Science 254:578-579. CrossRef Medline
23. Klewe IV, Nielsen SM, Tarp Ø L, Urizar E, Dipace C, Javitch JA, Gether U, Egebjerg J, Christensen KV (2008) Recruitment of beta-arrestin2 to the dopamine D2 receptor: insights into anti-psychotic and antiparkinsonian drug receptor signaling. Neuropharmacology 54:1215-1222. CrossRef Medline
24. Lawler CP, Prioleau C, Lewis MM, Mak C, Jiang D, Schetz JA, Gonzalez AM, Sibley DR, Mailman RB (1999) Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes. Neuropsychopharmacology 20:612-627. CrossRef Medline
25. Luscher C, Malenka RC (2011) Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron 69:650-663. CrossRef Medline
26. Madhavan A, He L, Stuber GD, Bonci A, Whistler JL (2010) micro-Opioid receptor endocytosis prevents adaptations in ventral tegmental area GABA transmission induced during naloxone-precipitated morphine withdrawal. J Neurosci 30:3276-3286. CrossRef Medline
27. Margolis EB, Mitchell JM, Ishikawa J, Hjelmstad GO, Fields HL (2008) Midbrain dopamine neurons: projection target determines action potential duration and dopamine D(2) receptor inhibition. J Neurosci 28:8908-8913. CrossRef Medline
28. Masri B, Salahpour A, Didriksen M, Ghisi V, Beaulieu JM, Gainetdinov RR, Caron MG (2008) Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics. Proc Natl Acad Sci U S A 105:13656-13661. CrossRef Medline
29. Mathis C, Bott JB, Candusso MP, Simonin F, Cassel JC (2011) Impaired striatum-dependent behavior in GASP-1-knock-out mice. Genes Brain Behav 10:299-308. CrossRef Medline
30. Mazza M, Squillacioti MR, Pecora RD, Janiri L, Bria P (2009) Effect of aripiprazole on self-reported anhedonia in bipolar depressed patients. Psychiatry Res 165:193-196. CrossRef Medline
31. Mercuri NB, Saiardi A, Bonci A, Picetti R, Calabresi P, Bernardi G, Borrelli E (1997) Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice. Neuroscience 79:323-327. CrossRef Medline
32. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998) Dopamine receptors: from structure to function. Physiol Rev 78:189-225. Medline
33. Moore RJ, Vinsant SL, Nader MA, Porrino LJ, Friedman DP (1998) Effect of cocaine self-administration on dopamine D2 receptors in rhesus monkeys. Synapse 30:88-96. CrossRef Medline
34. Saal D, Dong Y, Bonci A, Malenka RC (2003) Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37:577-582. CrossRef Medline
35. Schilström B, Yaka R, Argilli E, Suvarna N, Schumann J, Chen BT, Carman M, Singh V, Mailliard WS, Ron D, Bonci A (2006) Cocaine enhances NMDA receptor-mediated currents in ventral tegmental area cells via dopamine D5 receptor-dependent redistribution of NMDA receptors. J Neurosci 26:8549-8558. CrossRef Medline
36. Shelton RC, Osuntokun O, Heinloth AN, Corya SA (2010) Therapeutic options for treatment-resistant depression. CNS Drugs 24:131-161. CrossRef Medline
37. Thompson D, Whistler JL (2011) Trafficking properties of the D5 dopamine receptor. Traffic 12:644-656. CrossRef Medline
38. Thompson D, Martini L, Whistler JL (2010) Altered ratio of D1 and D2 dopamine receptors in mouse striatum is associated with behavioral sensitization to cocaine. PLoS One 5:e11038. CrossRef Medline
39. Ungless MA, Whistler JL, Malenka RC, Bonci A (2001) Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 411:583-587. CrossRef Medline
40. Wanat MJ, Hopf FW, Stuber GD, Phillips PE, Bonci A (2008) Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih. J Physiol 586:2157-2170. CrossRef Medline
41. Zhang H, Kiyatkin EA, Stein EA (1994) Behavioral and pharmacological modulation of ventral tegmental dendritic dopamine release. Brain Res 656:59-70. CrossRef Medline
42. Zweifel LS, Argilli E, Bonci A, Palmiter RD (2008) Role of NMDA receptors in dopamine neurons for plasticity and addictive behaviors. Neuron 59: 486-496. CrossRef Medline